Notably, HDAC6 inhibition activates DNA damage repair pathways by upregulating cellular stress genes such as DDIT4 (RTP801/Dig2/REDD1) and DDIT3 (CHOP/GADD153), highlighting its potential as a therapeutic target in cancer treatment [25]. Here, DDIT4 is linked to cancer.